Healthy Volunteers Clinical Trial
Official title:
Physiological and Psychosomatic Effects of Exposure to MRI Scanning Environment
Verified date | September 27, 2019 |
Source | National Institutes of Health Clinical Center (CC) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Background:
- Magnetic resonance imaging (MRI) creates high-quality images of the human body without
x-rays. It uses a strong magnetic field and radio waves to take pictures. Researchers want to
test a scanner that uses a high magnetic field strength.
Objective:
- To study how the body responds to being in a high field 11.7T MRI scanner.
Eligibility:
- Healthy people ages 22 65.
Design:
- Participants will be screened with a medical history and physical exam. They will
complete a healthy volunteer questionnaire and an MRI safety screening form. They may
have a 3T MRI scan of the brain.
- Participants will have an MRI scan. They will lie on a table that will slide in and out
of the MRI cylinder very slowly. They will be asked to lie still.
- Participants will do simple tasks while inside the machine. These can include listening
and responding to questions, tapping fingers, or moving a hand.
- While in the scanner, participants will hear loud knocking noises. They will get
earmuffs.
- Right when they exit the scanner, participants will get a questionnaire to fill out.
This will ask about how they felt inside the scanner.
- During the MRI, participants heart rate, respiratory rate, and skin temperature will be
measured. Before and after the scan, these things plus blood pressure will be measured.
- Participants will be tested before and after being in the MRI scanner. They will answer
questions, take pen-and-paper or computer tests, and do simple actions. Their sense of
smell may be tested.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | September 27, 2019 |
Est. primary completion date | September 27, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 22 Years to 65 Years |
Eligibility |
- INCLUSION CRITERIA: - 22 - 65 years of age - In good general health - Able to understand the procedures and requirements and give informed consent - Fluent in English EXCLUSION CRITERIA: All Subjects will answer the NMR safety screening form and the Healthy volunteer form A subject will be excluded if he/she: - Has any implanted medical device - Underwent brain surgery, have a central nervous system illness, a neurological lesion or history of neurological or psychiatric disorders - Medical problems, such as diabetes mellitus, hypertension, pulmonary or airway disease, heart failure, coronary artery disease, history of sleep apnea - Diagnosable substance dependence - Consumes more than 1 alcoholic drink per day for women and up to 2 drinks per day for men on a regular basis - Has any metal in their body due to by trauma or surgery - Cannot lie comfortably on their back for up to 60 minutes - Is pregnant - Have sustained shrapnel injuries - Has worked as a machinist, or other occupations that have resulted in metal shavings in their eye - Has claustrophobia - Has known hearing problems |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
National Institute of Neurological Disorders and Stroke (NINDS) |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Neuropsychological tests | 2 years | ||
Primary | Physiological parameters | 2 years | ||
Primary | Subjective experience parameters | 2 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |